摘要
支气管哮喘(简称哮喘)发病率正逐年上升,其发病机制十分复杂。目前认为Th1/Th2反应失衡导致Th2细胞增多是其重要的发病机制之一,其中Th2细胞产生的细胞因子白介素4在哮喘发病中起重要的作用,成为新的哮喘治疗靶点。
The incidence of Bronchial asthma (asthma) is increasing year hy year, hesides, the pathogenesis is very complex. Nowadays, it is believed that imbalance of Th1/Th2 response leading to excessively create of Th2 cells is one of the important pathogenesis. IL-4 produced by Th2 cells play an important role in asthma, understanding IL-4 in asthma may lead to new target to therapy in the future.
出处
《国际呼吸杂志》
2011年第9期691-695,共5页
International Journal of Respiration
关键词
哮喘
白介素4
靶向治疗
Asthma
Interleukin-4
Targeted therapy